Exercise Training Reduces Neointimal Growth and Stabilizes Vascular Lesions Developing after Injury in Apolipoprotein E-Deficient Mice

Circulation

Volumn 109, Issue 3, 2004, Pages 386-392

  Pynn, Marianne ^a   Schäfer, Katrin ^a   Konstantinides, Stavros ^a   Halle, Martin ^a,b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Atherosclerosis; Cholesterol; Exercise; Plaque; Thrombosis

Indexed keywords

ALPHA ACTIN; APOLIPOPROTEIN E; COLLAGEN FIBER; FERRIC CHLORIDE; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE SYNTHASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOPLASTIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTERY INTIMA; ARTERY INTIMA PROLIFERATION; ARTERY MEDIA; ARTERY WALL; ARTICLE; BODY WEIGHT; CAROTID ARTERY INJURY; CAROTID ARTERY THROMBOSIS; CONTROLLED STUDY; EXERCISE; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; LIPID BLOOD LEVEL; MORPHOMETRICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREADMILL;

ANIMALS; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; CAROTID ARTERY DISEASES; CAROTID STENOSIS; CELL DIVISION; EXERCISE THERAPY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PHYSICAL CONDITIONING, ANIMAL; THROMBOSIS;

EID: 1642580520     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000109500.03050.7C     Document Type: Article

References (24)

1. Sesso HD, Paffenbarger RS Jr, Lee IM. Physical activity and coronary heart disease in men: the Harvard Alumni Health Study. Circulation. 2000;102:975-980.
2. Myers J, Prakash M, Froelicher V, et al. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346:793-801.
3. Shephard RJ, Balady GJ. Exercise as cardiovascular therapy. Circulation. 1999;99:963-972.
4. Kraus WE, Houmard JA, Duscha BD, et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med. 2002;347:1483-1492.
5. Blair SN, Kampert JB, Kohl HW III, et al. Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women. JAMA. 1996;276:205-210.
6. Glass CK, Witztum JL. Atherosclerosis: the road ahead. Cell. 2001;104:503-516.
7. Breslow JL. Mouse models of atherosclerosis. Science. 1996;272:685-688.
8. Zhu Y, Farrehi PM, Fay WP. Plasminogen activator inhibitor type 1 enhances neointima formation after oxidative vascular injury in atherosclerosis-prone mice. Circulation. 2001;103:3105-3110.
9. Schäfer K, Konstantinides S, Riedel C, et al. Different mechanisms of increased luminal stenosis after arterial injury in mice deficient for urokinase- or tissue-type plasminogen activator. Circulation. 2002;106:1847-1852.
10. Aikawa M, Rabkin E, Okada Y, et al. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation. 1998;97:2433-2444.
11. Schäfer K, Müller K, Hecke A, et al. Enhanced thrombosis in atherosclerosis-prone mice is associated with increased arterial expression of PAI-1. Arterioscler Thromb Vasc Biol. 2003;23:2097-2103.
12. Thompson PD, Buchner D, Pina IL, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation. 2003;107:3109-3116.
13. Aikawa M, Rabkin E, Sugiyama S, et al. An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro. Circulation. 2001;103:276-283.
14. Pearson TA, Blair SN, Daniels SR, et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation. 2002;106:388-391.
15. Niebauer J, Maxwell AJ, Lin PS, et al. Impaired aerobic capacity in hypercholesterolemic mice: partial reversal by exercise training. Am J Physiol. 1999;276:H1346-H1354.
16. Konstantinides S, Schafer K, Loskutoff DJ. Do PAI-1 and vitronectin promote or inhibit neointima formation? The exact role of the fibrinolytic system in vascular remodeling remains uncertain. Arterioscler Thromb Vasc Biol. 2002;22:1943-1945.
17. Aikawa M, Voglic SJ, Sugiyama S, et al. Dietary lipid lowering reduces tissue factor expression in rabbit atheroma. Circulation. 1999;100:1215-1222.
18. Rong JX, Li J, Reis ED. et al. Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content. Circulation. 2001;104:2447-2452.
19. Halle M, Berg A, Northoff H, et al. Importance of TNF-alpha and leptin in obesity and insulin resistance: a hypothesis on the impact of physical exercise. Exerc Immunol Rev. 1998;4:77-94.
20. Ziccardi P, Nappo F, Giugliano G, et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation. 2002;105;804-809.
21. Indolfi C, Torella D, Coppola C, et al. Physical training increases eNOS vascular expression and activity and reduces restenosis after balloon angioplasty or arterial stenting in rats. Circ Res. 2002;91:1190-1197.
22. Tomita H, Egashira K, Kubo-Inoue M, et al. Inhibition of NO synthesis induces inflammatory changes and monocyte chemoattractant protein-1 expression in rat hearts and vessels. Arterioscler Thromb Vasc Biol. 1998;18:1456-1464.
23. Fukai T, Siegfried MR, Ushio-Fukai M, et al. Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training. J Clin Invest. 2000;105:1631-1639.
24. Niebauer J, Maxwell AJ, Lin PS. et al. NOS inhibition accelerates atherogenesis: reversal by exercise. Am J Physiol Heart Circ Physiol. 2003;285:H535-H540.